{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:25:28Z","timestamp":1782347128965,"version":"3.54.5"},"reference-count":30,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T00:00:00Z","timestamp":1340582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2012,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the efficacy and complications of bevacizumab versus 5-fluorouracil (5-FU)-augmented bleb needling of failed filtration blebs following trabeculectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Twenty-seven eyes of 27 patients with bleb failure were included. Patients were randomly assigned to receive either 5-FU or bevacizumab. Needling was performed in the operating room under sterile conditions. After the needling procedure, a viscoelastic material was injected subconjunctivally around the bleb area to avoid the entrance of 5-FU or bevacizumab into the anterior chamber. Bevacizumab (1.25\u2009mg\/0.1\u2009mL) was injected into 12 eyes and 5-FU injected into 15 eyes subconjunctivally. All of the patients were controlled weekly until a filtration bleb was maintained. Intraocular pressure (IOP), bleb appearance, and complications were noted in each group. Success was defined as absolute if the IOP 21\u2009mmHg or less without any medication or surgical intervention at last visit, and qualified if the IOP 21\u2009mmHg or less with topical antiglaucomatous medications. The patients were followed from 11 to 26 (median, 17) months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The IOP decreased, from 31.2\u00b13.2\u2009mmHg to 16.1\u00b12.1\u2009mmHg, in the bevacizumab group on the first postoperative day. The IOP was within normal limits in 1 (8.3%) patient without medication and controlled with topical antiglaucomatous drops in 2 (16.7%) patients. The total success rate was 25% at the time of the last visit. Success was not achieved in 9 (75%) eyes. The IOP was 32.0\u00b14.6\u2009mmHg preoperatively and 12.2\u00b12.6\u2009mmHg on the first postoperative day in the 5-FU injected patients. The total success rate was 80%; 8 (53.3%) eyes showed absolute success, whereas 4 (26.7%) eyes showed a qualified success. A statistically significant difference between groups in terms of success rates was observed (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Subconjunctival 5-FU application is a more effective therapy than bevacizumab application for needling procedures in failed trabeculectomy blebs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jop.2012.0035","type":"journal-article","created":{"date-parts":[[2012,6,27]],"date-time":"2012-06-27T01:51:49Z","timestamp":1340761909000},"page":"542-546","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of Needle Revision with Subconjunctival Bevacizumab and 5-Fluorouracil Injection of Failed Trabeculectomy Blebs"],"prefix":"10.1177","volume":"28","author":[{"given":"Tulay","family":"Simsek","sequence":"first","affiliation":[{"name":"Ulucanlar Training and Research Eye Hospital","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali B.","family":"Cankaya","sequence":"additional","affiliation":[{"name":"Ulucanlar Training and Research Eye Hospital","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ufuk","family":"Elgin","sequence":"additional","affiliation":[{"name":"Ulucanlar Training and Research Eye Hospital","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2012,6,25]]},"reference":[{"key":"e_1_3_2_2_2","article-title":"Wound healing in glaucoma filtering surgery","volume":"32","author":"Skuta G.L.","year":"1987","unstructured":"Skuta G.L., , Parrish R.K.2. Wound healing in glaucoma filtering surgery. Major review. Surv. Ophthalmol., 32:149\u2013147. 1987.","journal-title":"Major review. Surv. Ophthalmol."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(98)00025-3"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.3.286"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022550125261"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)70431-3"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0896-1549(05)70211-X"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72010-0"},{"key":"e_1_3_2_9_2","first-page":"242","article-title":"Needling revision of failed filtering blebs with adjunctive 5-fluorouracil","volume":"24","author":"Shin D.H.","year":"1993","unstructured":"Shin D.H., , Juzych M.S., , Khatana A.K. et al. Needling revision of failed filtering blebs with adjunctive 5-fluorouracil. Ophthalmic Surg., 24:242\u2013248. 1993.","journal-title":"Ophthalmic Surg."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(96)30403-X"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181c38723"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20938"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20301"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2441"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3283360aad"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.06.009"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20060301-12"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2003.034256"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1998.172"},{"key":"e_1_3_2_20_2","first-page":"715","article-title":"Early and late postoperative application of 5-fluorouracil following trabeculectomy in refractory glaucoma","volume":"25","author":"Hefetz L.","year":"1994","unstructured":"Hefetz L., , Keren T., , Naveh N. Early and late postoperative application of 5-fluorouracil following trabeculectomy in refractory glaucoma. Ophthalmic Surg., 25:715\u2013719. 1994.","journal-title":"Ophthalmic Surg."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200502000-00009"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.07.009"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1994.1037"},{"key":"e_1_3_2_24_2","first-page":"1445","article-title":"Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing","volume":"152","author":"Nissen N.N.","year":"1998","unstructured":"Nissen N.N., , Polverini P.J., , Koch A.E. et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am. J. Pathol., 152:1445\u20131452. 1998.","journal-title":"Am. J. Pathol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3180de1d0a"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.08-2662"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-3949"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.03.025"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.6.753f"},{"key":"e_1_3_2_30_2","first-page":"279","article-title":"Ocular hypotony and choroidal effusion following bleb needling","volume":"24","author":"Potash S.D.","year":"1993","unstructured":"Potash S.D., , Ritch R., , Liebmann J. Ocular hypotony and choroidal effusion following bleb needling. Ophthalmic Surg., 24:279\u2013280. 1993.","journal-title":"Ophthalmic Surg."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.180729"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2012.0035","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2012.0035","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2012.0035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:37:49Z","timestamp":1777646269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2012.0035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,25]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10,1]]}},"alternative-id":["10.1089\/jop.2012.0035"],"URL":"https:\/\/doi.org\/10.1089\/jop.2012.0035","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,25]]}}}